USPTO serial 86370447
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Santhera Pharmaceuticals (Schweiz) AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG
Pratteln, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon08222014
PATRICK J. CONCANNON Locke Lord LLPPO BOX 1470Church Street StationNEW YORK, NY 10008-1470| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; reagents for scientific and medical research use | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases; muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; reagents for medical use | SECTION 8 - CANCELLED | — |
| 042 | Medical research; science research; medical and scientific research, namely conducting clinical trials; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; animal model testing and research for neuro-muscular and ophthalmological diseases | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 29, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 20, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 20, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 26, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 29, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 24, 2015 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 13, 2015 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 20, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 20, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 31, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 15, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 11, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2014 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Sep 2, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2014 | ALIE | ASSIGNED TO LIE | — |
| Aug 22, 2014 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 22, 2014 | NWAP | NEW APPLICATION ENTERED | — |